Eidos Therapeutics, Inc. (EIDX)


Eidos Therapeutics, Inc. (EIDX)

$43.77 USD

4.47 (11.37%)

Updated Aug 19 4:00pm

Add EIDX to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 216 in Medical - Pharmaceuticals

See all “A” rated Strong Buy stocks

EIDX Daily Price Range
EIDX 52-Week Price Range

EIDX Stock Chart More Charts


EIDX Price/Volume Stats

Current price $43.77
Prev. close $39.30
Day low $39.01
Day high $45.00
50-day MA $34.24
200-day MA $22.64
52-week high $45.00
52-week low $8.89
Volume 379,800
Avg. volume 151,086
Dividend yield N/A
Market Cap 1.61B

Eidos Therapeutics, Inc. (EIDX) Company Bio


Eidos Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on developing drugs to treat diseases caused by transthyretin (TTR) amyloidosis (ATTR). It is developing AG10, an orally-administered small molecule designed to stabilize tetrameric TTR, thereby halting at its outset the series of molecular events that give rise to ATTR. The company was incorporated in 2013 and is headquartered in San Francisco, California. Eidos Therapeutics, Inc. is a subsidiary of BridgeBio Pharma LLC.





EIDX News Stream


Event/Time News Detail
Loading, please wait...

EIDX Social Stream


Loading social stream, please wait...

View Full EIDX Social Stream

EIDX Returns

1-mo 25.60%
3-mo 59.22%
6-mo 188.91%
1-year 134.19%
3-year N/A
5-year N/A
YTD 218.10%
2018 N/A
2017 N/A
2016 N/A
2015 N/A
2014 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.3923 seconds.